Voting Rights Announcements | 4 June 2014 17:41


STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

04.06.2014 17:41

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Correction of the release dated April 17, 2014

Financière de l'Echiquier, Paris, France has notified us pursuant to sec.
21 para. 1 WpHG on 3 June 2014, that on 16 April 2014 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went below the threshold of 3% and that the percentage of voting rights on
that day amounted to 2.96% (348,851 voting rights). Of these, 0.29% (34,000
voting rights) are attributable to the company pursuant to sec. 22 para 1
sent. 1 no. 6 WpHG.



04.06.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------